Category: Press Release - Psilocybin Alpha

New Resource: Psychedelics Drug Development Tracker

MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD

MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD

Post published:January 20, 2021
Post category:Press Release

Tryp Therapeutics Invited to Present at “Investing in Psychedelics” Conference

Tryp Therapeutics Invited to Present at “Investing in Psychedelics” Conference

Post published:January 19, 2021
Post category:Press Release

Psyched Wellness Announces New OTCQB Ticker: PSYCF

Psyched Wellness Announces New OTCQB Ticker: PSYCF

Post published:January 19, 2021
Post category:Press Release

BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada

BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada

Post published:January 19, 2021
Post category:Press Release

NeonMind Lists on the Frankfurt Stock Exchange

NeonMind Lists on the Frankfurt Stock Exchange

Post published:January 19, 2021
Post category:Press Release

Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development

Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development

Post published:January 19, 2021
Post category:Press Release

Awakn Strengthens Scientific and Medical Leadership with Appointment of Chief Science Officer and Head of Ketamine Alcohol Use Disorder Practice

Awakn Strengthens Scientific and Medical Leadership with Appointment of Chief Science Officer and Head of Ketamine Alcohol Use Disorder Practice

Post published:January 19, 2021
Post category:Press Release

PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders

PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders

Post published:January 19, 2021
Post category:Press Release

Havn Life to Support Canadian Counterpart of Veterans’ Organization, Heroic Hearts

Havn Life to Support Canadian Counterpart of Veterans’ Organization, Heroic Hearts

Post published:January 18, 2021
Post category:Press Release

Lobe Sciences Announces Management Changes and New Director

Lobe Sciences Announces Management Changes and New Director

Post published:January 18, 2021
Post category:Press Release

End of content

No more pages to load

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.